Eyewire News: The Podcast

Eyewire News

Eyewire News: The Podcast keeps listeners updated with the latest information in the ophthalmic field, featuring breaking news from press releases, medical journals, vision publications, and other news sources.

115 Episoder

Ophthalmic Executives Provide Company Updates (Part 2 of 2)
4.11.2026
14:31
Leaders of several ophthalmic companies with a focus on the posterior segment provide updates on their pipeline and new products in this special edition of Eyewire News the Podcast. Learn more about your ad choices. Visit megaphone.fm/adchoices
Ophthalmic Executives Provide Company Updates (Part 1 of 2)
28.10.2026
18:51
Leaders of several thalamic companies provide updates on their pipeline and new products in the special edition of Eyewire News the Podcast. Learn more about your ad choices. Visit megaphone.fm/adchoices
Gå ikke glip af nogen episoder af “Eyewire News: The Podcast” - abonnér på podcasten med gratisapp GetPodcast.
Breaking News From the AAO Annual Meeting in New Orleans (Part 2 of 2)
22.10.2026
12:30
Eyewire News the Podcast reports on new products and breaking news live from thee American Academy of Ophthalmology meeting in New Orleans. Learn more about your ad choices. Visit megaphone.fm/adchoices
Breaking News From the AAO Annual Meeting in New Orleans (Part 1 of 2)
14.10.2026
10:09
Eyewire News the Podcast reports on new products and breaking news live from thee American Academy of Ophthalmology meeting in New Orleans. Learn more about your ad choices. Visit megaphone.fm/adchoices
Special Report: Potential of Robotic Cataract Surgery
7.10.2026
9:27
Leaders pioneering fully robotic assisted cataract surgery, discussed the technology and shared their experience treating the first human patients. Learn more about your ad choices. Visit megaphone.fm/adchoices
Kodiak Plans to Submit BLA for Zenkuda After Phase 3 Data
30.9.2026
6:37
Kodiak Sciences meets its primary endpoint in a phase 3 trial for its DME drug candidate clearing the way for a regulatory submission; the European Commission approves Roche’s Susvimo for wet AMD; and Merck announces topline results from a pivotal phase 2b/3 trial evaluating two doses of its DME treatment candidate. Learn more about your ad choices. Visit megaphone.fm/adchoices
Breaking News From the ESCRS Congress in London (Part 2 of 2)
23.9.2026
8:46
EyewireTV reports on new products and breaking news live from the ESCRS Congress in London. Learn more about your ad choices. Visit megaphone.fm/adchoices
Breaking News From the ESCRS Congress in London (Part 1 of 2)
16.9.2026
10:56
EyewireTV reports on new products and breaking news live from the ESCRS Congress in London. Learn more about your ad choices. Visit megaphone.fm/adchoices
FDA Accepts Nanoscopes's Optogenetic Gene Therapy BLA
9.9.2026
4:57
The FDA accepts a biologics license application (BLA) for a first-of-its-kind optogenetic gene therapy for RP; a software upgrade from Heru combines several pretesting assessments into a single guided workflow; and a new FDA-approved overnight orthokeratology lens is launched in the US. Learn more about your ad choices. Visit megaphone.fm/adchoices
FDA Sets PDUFA Date for Investigational Glaucoma Eye Drop
2.9.2026
6:17
The FDA accepts Nicox’s NDA for an investigational glaucoma drop; Bausch + Lomb provides updates on two key investigational therapies for dry eye and ocular surface pain; and Ocugen doses the first patient in a global phase 3 trial of an investigational gene therapy for geographic atrophy (GA). Learn more about your ad choices. Visit megaphone.fm/adchoices

Flere episoder

Få adgang til hele det store podcastunivers med gratisappen GetPodcast.

Abonnér på dine favoritpodcasts, lyt til episoder offline, og få spændende anbefalinger.

En virksomhed fra

Eyewire News: The Podcast

Eyewire News

115 Episoder

Ophthalmic Executives Provide Company Updates (Part 2 of 2)

Ophthalmic Executives Provide Company Updates (Part 1 of 2)

Breaking News From the AAO Annual Meeting in New Orleans (Part 2 of 2)

Breaking News From the AAO Annual Meeting in New Orleans (Part 1 of 2)

Special Report: Potential of Robotic Cataract Surgery

Kodiak Plans to Submit BLA for Zenkuda After Phase 3 Data

Breaking News From the ESCRS Congress in London (Part 2 of 2)

Breaking News From the ESCRS Congress in London (Part 1 of 2)

FDA Accepts Nanoscopes's Optogenetic Gene Therapy BLA

FDA Sets PDUFA Date for Investigational Glaucoma Eye Drop